FDA Approves Lung Cancer Drug Adagrasib

Oral secondary treatment was found to improve advanced cases in trials. The Food and Drug Administration (FDA) approved Mirai Therapeutic’s drug adagrasib for use in advanced lung cancer…

Read More

FDA Fields Increasing Reports of Ventilator Breakdowns

Issues with foam are suspected in recalled Philips model. The Food and Drug Administration (FDA) announced last week that it has received 48,000 reports for faulty ventilators and…

Read More

VA Adds Nine Cancers to Service-Connected Disabilities

Rare respiratory cancers linked to airborne carcinogens in the field. The Department of Veterans Affairs (VA) has added nine rare respiratory cancers to their list of disabilities caused…

Read More

Back to top
FE3